CLINICAL_TRIALS
trial_result
· 2013-12-19
Clinical Trial Update: A Rollover Study for Patients Who Participated in Other Romidepsin Protocols [Phase 2]
Summary
A Phase 2 rollover study for patients who participated in other romidepsin protocols has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Lymphoma, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-19